Skip to main content
Sign In

Immunology Graduate Program Faculty

The faculty included in this list are the members of the Graduate Program in Immunology. Any of the individuals listed may serve as laboratory rotation mentors and thesis advisors for Immunology Graduate Program students.

Rafeul Alam, MD, PhD - Signal transduction mechanism of eosinophil and T cells, and signaling mechanism of asthma
Scott Alper, PhD - Genetic control of TLR signaling pathways
Jeffrey Bennett, PhD - Neuro-immunology; mechanisms of neural and glial responses to me neuro-inflammatory disease
Willi Born, PhD - The biology of lymphocytes expressing gamma/delta T cell receptors
(gamma/delta T cells)
John C. Cambier, PhD - BCR Antigen Receptor Structure and signaling, MHC Class II signaling, Inhibitory “Checkpoint” Receptor Signaling Molecular basis of B cell anergy, Description of STING/MPYS, a transducer of innate immune signals
Eric Campbell, PhD - My laboratory is interested in crosstalk between the colonic epithelium, microbiota and innate immune system during homeostasis and inflammation. Current projects in my group focus on epithelial coordination of monocyte trafficking and polarity and epithelial metabolism modulating microbial niches
Eric Clambey, PhD - My research focuses on the dynamic interface between the immune system, inflammation and tissue repair. In particular, my lab studies how T cells, pivotal cells of the immune system, influence the balance between health and disease at mucosal surfaces, including the lung and gastrointestinal tract. These studies focus on diverse contexts, ranging from anti-viral to anti-tumor immunity, with an emphasis on immunomodulatory approches to limit infection and malignancy
J. John Cohen, MD, MC, PhD
Sean P. Colgan, PhD - Role of leukocytes, epithelium and hypoxia in inflammatory bowel disease
Shaodong Dai, PhD - Understanding the mechanisms of the metal containing ligands for alpha/beta TCRs from metal reactive human T cells
Howard W. Davidson, PhD - T and B cell responses to type 1 diabetes autoantigens in human and mouse
Eduardo Davila, PhD Our long-term goals are to develop novel approaches for treating immunorefractory cancers and to develop predictive models and diagnostics to identify compounds that sensitize tumors to T cell-based therapies.
James DeGregori, PhD - Pathways and mechanisms that contribute to leukemia initiation and maintenance
Kelly Doran, PhD - Studying host - pathogen interactions in the central nervous system (CNS) and the female reproductive during infection and colonization
Gregory P. Downey, MD - Acute Lung Injury and Repair, Epithelial Injury, Fibrosis, Chronic respiratory infections, asthma
Stephen Dreskin, MD, PhD - asthma, rhinitis, urticaria, sever food allergy, angioedema and immunodeficiency
Christopher Evans, PhD - Mucins in innate defense: determination of their immunomodulatory roles through direct activation of leukocyte glycan receptors
Andrew Fontenot, MD - Allergic lung disease; The role of T cells in the development of lung disease. In particular, the laboratory is interested in determining the mechanism by which CD4 T cells recognize the beryllium antigen in the context of HLA-DP2
Brian Freed, PhD - Immunogenetics
Rachel S. Friedman, PhD - Cell trafficking in type 1 diabetes; Immunotherapeutics development
Terry ​J. Fry, MD​ - CD4 CAR-T cells using the OTII model
Mayumi Fujita, M​D, PhD​ - Role of IL-37 in adaptive immunity and cancer immunosuppression
Laurent Gapin, PhD - Mechanisms of iNKT cell development and antigen recognition
Ronald G. Gill, PhD - Transplantation of pancreatic cells as a treatment for insulin-dependent diabetes
James R. Hagman, PhD - Regulation of B cell development, epigenetics and cancer
Kathryn Haskins, PhD - Immunoregulation in autoimmune diabetes; pancreatic beta-cell autoantigens
Peter Henson, PhD - Innate immunity, inflammation and apoptotic cell recognition
V. Michael Holers, MD - Complement-mediated tissue injury; preclinical autoimmune disease pathogenesis
Elena Hsieh, MD - Mechanistic and translational questions in human immunology using high-dimensional single-cell mass cytomerty and ex-vivo cellular manipulation
Hua Huang, MD, PhD - We study signaling and transcriptional regulation of genes that control innate effector cell development and function, with a focus on how master transcription factors induce a network of downstream transcription factors and how these transcription factors and their associated enhancers and promoters detect signal inputs triggered by immunological stimuli and convert them into transcriptional outputs in the normal and diseased immune system.
Elena Hsieh, MD​ - Mechanistic and translational questions in human immunology using high-dimensional single-cell mass cytometry and ex-vivo cellular manipulation
Jordan Jacobelli, PhD - Lymphocyte trafficking and cell-cell interactions in health and disease
Claudia V. Jakubzick, PhD - Dendritic cell differentiation and function
Edward N. Janoff, MD - Mucosal immunity; HIV transmission and vaccine; pneumococcal infections and vaccine; B cell regulation
John Kappler, PhD - Structure and function of the T-cell receptor and its ligands in autoimmunity, cancer and hypersensitivity
Ross Kedl, PhD - Intersection between innate and adaptive signals which lead to potent cellular immunity; exploration of how these signals might be manipulated for vaccine development and design
Marijke Keestra-Gounder, PhD - Elucidating pathways of innate immunity that can distinguish harmless microbes from pathogens, thereby enabling the host to mount responses that are commensurate with the threat
Elizabeth J. Kovacs, PhD - Overall focus: The effects of advanced age, alcohol intoxication, and radiation exposure on inflammatory responses after injury or infection
Kristine A. Kuhn, MD, PhD - Microbiome and mucosal immunity in the development of autoimmune diseases
Laurel L. Lenz, PhD - Molecular mechanisms of bacterial pathogenesis, host-bacteria interactions, host-directed therapeutics, innate immunity, interferons, Listeria monocytogenes
Philippa “Pippa” Marrack, PhD - T cell development; T-cell responses and death
Thomas E. “Tem” Morrison, PhD - Immunological mechanisms that influence the clearance or persistence of arboviruses and protozoan parasites; molecular mechanisms by which pathogens counteract host innate and adaptive immune responses
Maki Nakayama, MD, PhD - To understand the mechanism how anti-beta cell autoimmunity is initiated, my laboratory focus on the tri-molecular complex consisting of antigen, major histocompatibility complex (MHC), and T cell receptor (TCR), which could be a key component for the development of type 1 diabetes
Rebecca O’Brien, PhD - Specificity and function of gamma delta T lymphocytes
Brian P. O’Connor, PhD - Epigenetics, immune system, diet and asthma
Roberta Pelanda, PhD - Molecular mechanisms of B cell development and selection and the development of autoimmunity 
Eric Pietras, PhD - In my own laboratory I am leading detailed, cutting-edge investigations of how inflammation 1) directs HSC fate decisions that reshape the blood system and participates in the establishment of homeostasis, 2) negatively impacts HSC and blood system function in the context of chronic inflammation.
Terence “Terry” Potter, PhD - Immunogenetics
Lee Reinhardt, PhD​ - The role and regulation of CD4+ T cell subsets and their cytokines in settings of type-2 immunity, malignancy, and autoinflammatory disease
Nichole Reisdorph, PhD - Proteomics, metabolomics and disease
David W.H. Riches, PhD - Basic mechanisms involved in the development lung inflammation and fibrosis
Rosemary Rochford, PhD - Co-infections with and immune responses to human gammaherpesviruses and P. falciparum malaria
Mario L. Santiago, PhD - Innate host restriction and adaptive immunity against pathogenic retroviruses
David Schwartz, MD - Effects of microbiome on the innate immune system
Jill Slansky, PhD - Immune response to cancer
Beth Tamburi​ni, PhD​ - Understand the mechanisms behind antigen transfer from non-hematopoietic to hematopoietic cells in order to enhance protective immunity
Joshua Thurman, MD - The role of the complement system in inflammatory injury
Raul Torres, PhD - B cell development and antibody response, regulation of tumor immunity by lysophospholipids
Kenneth Tyler, MD - Our laboratory studies mechanisms of virus-induced CNS injury and the nature of CNS-specific host-inate immune responses using reoviruses, flaviviruses (West Nile, Japanese Encephalitis, Zika) in a variety of experimental systems including primary cell culture, ex vivo brain and spinal cord slices and mice
Linda F. van Dyk, PhD - Genetic and molecular approaches to infection and pathogenesis by lymphotropic herpesviruses
Andrés Vázquez-Torres, DVM Ph.D. - Molecular and redox determinants in the pathogenesis of intracellular bacteria
Michael Verneris, MD​ - Developing cellular therapy to reduce leukemia recurrence by enhancing immune recovery and by more effectively treating sites of leukemia (with a newly developed method of bone marrow irradiation
David H. Wagner, Jr., PhD - Role of CD40 in Autoimmune Inflammation
Jing H. Wang, MD, PhD - Immune Evasion of Cancers, Genomic instability in B cells, Regulation of Secondary Antibody Gene Diversification
Cara Wilson, MD - Immune Evasion of Cancers, Genomic instability in B cells, Regulation of Secondary Antibody Gene Diversification
Lawrence Wysocki, PhD - Somatic mutagenesis in immunity and autoimmunity
Gongyi Zhang, PhD - Structural and functional studies of proteins, epigenetics